The Capital Group Companies, Inc. reduced its holding of INNOVENT BIO (01801) by approximately 3,327,400 shares at a price of around HK$31.55 per share.
On January 20th, The Capital Group Companies, Inc. reduced its holdings in Sino Biopharmaceutical (01801) by 3,327,405 shares, priced at 31.5469 Hong Kong dollars per share, for a total amount of approximately 105 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on January 20, The Capital Group Companies, Inc. reduced its holdings of INNOVENT BIO (01801) by 3,327,405 shares, at a price of 31.5469 Hong Kong dollars per share, with a total amount of approximately 105 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 96,778,400 shares, with a shareholding proportion of 5.91%.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
